Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients

BACKGROUND: Plasma calprotectin is a potential biomarker of cardiovascular disease (CVD), insulin resistance (IR), and obesity. We examined the relationship between plasma calprotectin concentrations, CVD manifestations and the metabolic syndrome (MetS) in patients with type 2 diabetes mellitus (T2D...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Lise, Nybo, Mads, Poulsen, Mikael Kjær, Henriksen, Jan Erik, Dahl, Jordi, Rasmussen, Lars Melholt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289556/
https://www.ncbi.nlm.nih.gov/pubmed/25527236
http://dx.doi.org/10.1186/1471-2261-14-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289556/
https://www.ncbi.nlm.nih.gov/pubmed/25527236
http://dx.doi.org/10.1186/1471-2261-14-196

Ejemplares similares